Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,801 stories, page 220 of 631

Advanced search

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

California biotech’s at-home urine test aims to catch cancer early

The Mercury NewsOriginal source

🌍Aug 21Researchnews.uci.eduTier 2 · Direct publisher

Lab-grown brain models gain a sense of place

University of California IrvineOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

America’s biotech security push — and Italy’s challenge

Decode39Original source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade) (NYSEARCA:XBI)

Seeking AlphaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moderna Breakthrough Sends MRNA Soaring: 4 mRNA Cancer Vaccine Stocks to Buy Instead

MarketWiseOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

BBP: The Biotech ETF That Filters For FDA-Approved Drugs (NYSEARCA:BBP)

Seeking AlphaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Tufts' new hub aims to bridge biotech and food manufacturing

The Business JournalsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Biotech announces $750M expansion in Hillsboro

KGWOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

How RU-486 Got to America

National Right to Life CommitteeOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Sol-Gel reports $0.6M Q2 revenue as SGT-610 trial advances

grafa.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Why Iovance Biotherapeutics Stock Hit 52-Week High

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Tempus AI’s biotech deal attracts investor attention

SemaforOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

AC Immune Says Early Data from Anti-Inflammatory Drug Gives Wider Clinical Momentum for Pipeline

BenzingaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA tightens crackdown on adulterated edible oil

DaijiworldOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Regeneron to challenge Ipsen as FDA clears bone disease drug

BioPharma DiveOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moderna's 177% Surge Powers a Broad Biotech Rally

ETF.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Why Biotech Companies Need to Think Beyond Development Earlier

BioPharm InternationalOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

WHO Confirms COVID-19 Vaccines in Phase 3 Clinical Trials

Nigeria Communications WeekOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Biotech Is Booming, But These 2 Stocks Missed the Memo - Moderna (NASDAQ:MRNA), iShares Biotechnology ETF

BenzingaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Karnataka Forms SIT To Probe Bidadi Drug Repacking Case, Related Cases Across State

The Bengaluru LiveOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Vimal Elaichi Ad Row: No reply yet from celebrities to FDA notices; action after deadline, says Tukaram Mundhe

Zee BusinessOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial

StocktwitsOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)

Yahoo FinanceOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

To outcompete China, unhandcuff America’s biotech innovators

The HillOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

FDA records GH¢70m surplus, flags ageing laboratory equipment

CitiNewsroom.comOriginal source

🌍Aug 20Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Provides Second Quarter 2026 Financial and Operating Highlights

HeartSciencesOriginal source

🌍Aug 20Mediaheartsciences.comTier 2 · Direct publisher

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

HeartSciencesOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Moderna's Personalised Cancer Vaccine Clears Phase 3: How Soon Could Patients Receive It?

International Business TimesOriginal source

🇺🇸Aug 20CROppd.comTier 2 · Direct publisher

Governance, data and talent: what to plan before moving to a mixed FSP/FSO model

Thermo Fisher PPDOriginal source

🇺🇸Aug 20CROcelerion.comTier 2 · Direct publisher

When to Run a UGT-Mediated DDI Trial—and Why It Matters Clinically

CelerionOriginal source

🌍Aug 20discoverynews.google.comTier 2 · Trade media

Chai tees up Bristol Myers Squibb AI antibody discovery collab

Fierce BiotechOriginal source

🌍Aug 20discoverynews.google.comTier 2 · Trade media

Scribe’s early-stage IPO standout defies biotech’s derisking trend

BioSpaceOriginal source

🌍Aug 20Researchnews.uci.eduTier 2 · Direct publisher

Math and medicine join forces to solve a cancer mystery

University of California IrvineOriginal source

🌍Aug 20Researchanswers.childrenshospital.orgTier 2 · Direct publisher

My own secret superpower: Jocelyn’s journey with C3 glomerulopathy

Boston Children's HospitalOriginal source

🇺🇰Aug 20Regulatorygov.ukTier 1 · Regulatory source

Public health commissioning in the NHS: 2026 to 2027

Information about NHS England's objectives and funding arrangements as it commissions public health...

UK Department of Health and Social CareOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Healthcare CDMO (2026-2031) - Growing Outsourcing of Pharmaceutical Development and Manufacturing Drives Market Growth

Yahoo Finance UKOriginal source

🌍Aug 20discoverynews.google.comTier 2 · Trade media

B. Braun recalls IV solution from US, Canada hospitals on particle contamination concerns

Fierce PharmaOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips

Pharmaceutical CommerceOriginal source

🇺🇰Aug 20Researchstgeorges.nhs.ukTier 2 · Direct publisher

Plans being developed for a new Mental Health Emergency Department at St George’s

St George's University HospitalsOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up After Analyst Upgrade

MarketBeatOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

10x Genomics dealt major blow in sequencing fight

Life Sciences IP ReviewOriginal source

🇺🇰Aug 20Devicespresspart.comTier 1 · Company source

Partnership Begins Before Production – Christian Krätzig on Collaboration as Equals

H&T PresspartOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?

The Motley FoolOriginal source

🇺🇰Aug 20Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Oxford researchers win prestigious national leadership prizes

Oxford MedicineOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Moderna stock falls 20% after record rally as valuation concerns emerge

TradingViewOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Pharmacists’ Look at the Future of GLP-1 Compounding

Drug TopicsOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

AI-Driven Cancer Vaccine Passes Phase 3 Trials

ForkLogOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

ExpreS2ion Biotech: Operating income surged 238% YoY as clinical pipeline advanced and cash was bolstered by a rights issue

TradingViewOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-Led FDA Bans Sale of Loose Edible Oil in Maharashtra; Warns of Action Against Violators

lokmattimes.comOriginal source

🌍Aug 20discoverynews.google.comTier 2 · Trade media

Meet Aletta: The first FDA approved robotic blood draw device

Fierce BiotechOriginal source

🌍Aug 20discoverynews.google.comTier 2 · Trade media

FDA approves Ultragenyx gene therapy

STATOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth

Zacks Investment ResearchOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate

simplywall.stOriginal source

🌍Aug 20Mediaskpharmteco.comTier 3 · Secondary coverage

SK pharmteco to Attend CPHI, Showcasing Multimodal CDMO Capabilities and Global Manufacturing Infrastructure

SkpharmtecoOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

The First-Ever Personalized Cancer Vaccine to Pass a Phase 3 Trial Just Beat Keytruda Alone

Cure TodayOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

FDA records GH¢70m surplus in 2025 despite laboratory equipment, illicit product concerns

MyJoyOnlineOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Evaxion Biotech Q2 2026 Earnings Call: Complete Transcript

BenzingaOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Pune FDA Crackdown: 3 Food Licences Suspended, Products Worth ₹19.90 Lakh Seized - PHOTOS

Free Press JournalOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

Once-weekly insulin would be ‘significant change’ for diabetes prescribers

The Pharmaceutical JournalOriginal source

🌍Aug 20discoverynews.google.comTier 3 · Aggregated media

AI Disrupts Topical Drug Delivery as Billion-Dollar

GlobeNewswireOriginal source